Previous chapter:
Chapter 1720 - 1236
Next chapter:
Chapter 1722 - 1237: Six People?
PREVIEW
... e was overshadowed by Merck’s 4-valent and 9-valent HPV vaccines in terms of valency. However, by incorporating a new, superior adjuvant of its own development into the recombinant herpes zoster vaccine Shingrix, it ultimately outperformed Merck’s herpes zoster vaccine and successfully turned the tables.
Merck’s Zostavax is a live attenuated herpes zoster virus vaccine that was the king of herpes zoster vaccines before the advent of Shingrix, with an unshakable position.
But the ...
YOU MAY ALSO LIKE





























